ZURICH, Sept 9 The following are some of the
main factors expected to affect Swiss stocks on Friday:
German chemicals and crop pesticides firm Bayer
is exploring the sale of its dermatology business to push
forward its deal with, Bloomberg reported, citing
sources. The business, which could fetch 1 billion euros ($1.13
billion) could attract interest from Nestle, Allergan
and Almirali, the report said.
* Novartis introduced a new asthma test for rapid
diagnosis of severe allergic asthma.
* Gurit won four-year automotive supply contract
with a British maker of car parts worth around 15 million Swiss
francs ($15.45 million), the Swiss company said.
* The Swiss unemployment rate rose to a non-seasonally
adjusted 3.2 percent in August from 3.1 percent in the previous
month, the State Secretariat for Economic Affairs said on
($1 = 0.9711 Swiss francs)
($1 = 0.8869 euros)
(Reporting by Zurich newsroom)